ES2029030T3 - Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona. - Google Patents

Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona.

Info

Publication number
ES2029030T3
ES2029030T3 ES198888310599T ES88310599T ES2029030T3 ES 2029030 T3 ES2029030 T3 ES 2029030T3 ES 198888310599 T ES198888310599 T ES 198888310599T ES 88310599 T ES88310599 T ES 88310599T ES 2029030 T3 ES2029030 T3 ES 2029030T3
Authority
ES
Spain
Prior art keywords
pirido
pirimidin
ona
tetrazole
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888310599T
Other languages
English (en)
Inventor
Takashi Yazaki
Kazunori Takuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Application granted granted Critical
Publication of ES2029030T3 publication Critical patent/ES2029030T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PREPARACION ACUOSA PARA EL TRATAMIENTO DE ENFERMEDADES ALERGICAS QUE COMPRENDE LA SAL POTASICA 9 - METIL - 3 - (1H TETRAZOL - 5 - IL) - 4H - PIRIDO[1,2-A]PIRIMIDIN - 4 - ONA, FOSFATO POTASICO DIBASICO Y FOSFATO POTASICO MONOBASICO. LA PREPARAQCION NO PRODUCE IRRITACION LOCAL Y TIENE ESTABILIDAD FISICO - QUIMICA DURANTE EL ALMACENAMIENTO A LARGO PLAZO.
ES198888310599T 1987-11-10 1988-11-10 Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona. Expired - Lifetime ES2029030T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62282064A JP2504788B2 (ja) 1987-11-10 1987-11-10 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤

Publications (1)

Publication Number Publication Date
ES2029030T3 true ES2029030T3 (es) 1992-07-16

Family

ID=17647679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888310599T Expired - Lifetime ES2029030T3 (es) 1987-11-10 1988-11-10 Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona.

Country Status (7)

Country Link
US (1) US4977157A (es)
EP (1) EP0316174B1 (es)
JP (1) JP2504788B2 (es)
AU (1) AU603712B2 (es)
CA (1) CA1317230C (es)
DE (1) DE3863625D1 (es)
ES (1) ES2029030T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662417B2 (ja) * 1987-12-25 1994-08-17 参天製薬株式会社 抗アレルギー点眼液
JP3310994B2 (ja) * 1991-07-03 2002-08-05 電気化学工業株式会社 アレルギー治療剤
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
RU2115413C1 (ru) * 1997-03-03 1998-07-20 Малое государственное предприятие "Научно-экспериментальное производство" Ирригационный раствор "интрасол"
WO2006099651A1 (de) * 2005-03-24 2006-09-28 Unipack Ges.M.B.H. Flüssige, wässrige darreichungsform für sublinguale oder nasale anwendungen von aminorgruppen aufweisenden wirkstoffen
NZ577467A (en) * 2006-12-18 2012-04-27 Cardoz Ab Combination of pemirolast and a statin for use in the treatment of inflammatory disorders
EP2107907B1 (en) * 2006-12-20 2012-02-01 Cardoz AB Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007673A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
EP2443120B1 (en) 2009-06-16 2016-11-02 RSPR Pharma AB Crystalline form of pemirolast
US20160243122A1 (en) 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
CN116531383A (zh) * 2023-05-09 2023-08-04 安徽四环科宝制药有限公司 含吡嘧司特钾的药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
JPH0662417B2 (ja) * 1987-12-25 1994-08-17 参天製薬株式会社 抗アレルギー点眼液

Also Published As

Publication number Publication date
CA1317230C (en) 1993-05-04
AU603712B2 (en) 1990-11-22
EP0316174A1 (en) 1989-05-17
US4977157A (en) 1990-12-11
AU2433488A (en) 1989-05-11
DE3863625D1 (de) 1991-08-14
JPH01125321A (ja) 1989-05-17
EP0316174B1 (en) 1991-07-10
JP2504788B2 (ja) 1996-06-05

Similar Documents

Publication Publication Date Title
ES2029030T3 (es) Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona.
FR2492382B1 (es)
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
AU582920B2 (en) Continuous release pharmaceutical compositions
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
FI882692L (fi) Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
ES2191669T3 (es) Compuestos opticamente activos.
MX162265A (es) Procedimiento mejorado para la preparacion de acido 4-dimetilamino-1-hidro-xibutano-1,1-difosfonico
MX25305A (es) Procedimiento para preparar sales de amonio de acido n5-metil-5,6,7,8-tetrahidrofolico.
HUT47385A (en) Herbicides comprising aryloxy-(or thio)-amino-pyrimidine derivatives as active ingredient and process for producing the active ingredients and their intermediates
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
SE9300758D0 (sv) Process for the production of clavulanic acid
NO870123D0 (no) Mastittvaksine.
ES2054777T3 (es) Metodo para la preparacion de o-carboxiarilimidazolinonas.
HUT48096A (en) Insecticides comprising 2-imino-1,3-dithiethane derivatives as active ingredient and process for producing the active ingredients
ES2015896B3 (es) Sal de una morfolina sustituida con acido fluoborico y agente para la proteccion de la madera.
ES2069990T3 (es) Acido acilaminoalquilidenhidroxibisfosfonico util en la terapia de enfermedades osteoarticulares.
EP0432700A3 (en) Use of lithium compounds for the treatment of combination skin
AT367016B (de) Verfahren zur herstellung von neuen benzoylphenoxy-alkansaeurederivaten und von deren salzen mit saeuren bzw. basen
FI881032A7 (fi) Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi.
JPS5448711A (en) Racemization of optical active nnacyllamino acid in the atate of aqueous solution
ES2126643T3 (es) Sales de un acido quinoloncarboxilico.
ATA446777A (de) Verfahren zur herstellung neuer pyrido(1,2-a) pyrimidin-derivate, deren optisch aktiver isomere und physiologisch vertraeglicher salze
DE3764457D1 (de) Empfaengnisverhuetende, waessrig-saure zusammensetzung und verfahren zu ihrer herstellung.
IT8122635A0 (it) Metodo per la preparazione delgamma-etil estere dell'acido l-glutamminico per uso farmaceutico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316174

Country of ref document: ES